logo
CONTENT TYPES

Figure 1Loading Img

Heterologous and High Production of Ergothioneine in Escherichia coli

View Author Information
Graduate School of Chemical Science and Engineering and Graduate School of Engineering, Hokkaido University, Sapporo, Hokkaido 060-8628, Japan
§ Innovation Medical Research Institute, University of Tsukuba, Tsukuba, Ibaraki 305-8550, Japan
*Telephone: +81-11-706-7815. Fax. +81-11-706-7118. E-mail: [email protected]
*Telephone: +81-11-706-7815. Fax. +81-11-706-7118. E-mail: [email protected]
Cite this: J. Agric. Food Chem. 2018, 66, 5, 1191–1196
Publication Date (Web):December 25, 2017
https://doi.org/10.1021/acs.jafc.7b04924
Copyright © 2017 American Chemical Society
ACS Editors’ ChoiceACS Editors’ Choice
Article Views
4264
Altmetric
-
Citations
LEARN ABOUT THESE METRICS

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.

PDF (858 KB)
Supporting Info (1)»

Abstract

Ergothioneine (ERG) is a histidine-derived thiol compound suggested to function as an antioxidant and cytoprotectant in humans. Therefore, experimental trials have been conducted applying ERG from mushrooms in dietary supplements and as a cosmetic additive. However, this method of producing ERG is expensive; therefore, alternative methods for ERG supply are required. Five Mycobacterium smegmatis genes, egtABCDE, have been confirmed to be responsible for ERG biosynthesis. This enabled us to develop practical fermentative ERG production by microorganisms. In this study, we carried out heterologous and high-level production of ERG in Escherichia coli using the egt genes from M. smegmatis. By high production of each of the Egt enzymes and elimination of bottlenecks in the substrate supply, we succeeded in constructing a production system that yielded 24 mg/L (104 μM) secreted ERG.

Introduction

ARTICLE SECTIONS
Jump To

Ergothioneine (ERG), a histidine-derived thiol compound, was isolated from an ergot fungus, Claviceps purpurea, more than a century ago. ERG is also known to be synthesized in actinobacteria, cyanobacteria, and a fission yeast.(1-3) Recent studies show that ERG functions as an antioxidant, such as glutathione, mycothiol, and bacillithiol. There is no direct evidence for biosynthesis of ERG in humans. However, ERG has been reported to be accumulated in various cells and tissues at high concentrations, probably by intake from diets, such as mushrooms and red beans, that contain relatively large amounts of ERG through an ERG-specific organic cation transporter, OCTN1.(4, 5)
The presence of the ERG-specific transporter and the extensive accumulation of ERG in tissues suggest that ERG should have significant biological functions in humans. Although the true physiological role of ERG in humans has yet to be fully understood, ERG has been shown by in vitro experiments to function as an antioxidant and a cytoprotectant. Therefore, applications of ERG in dietary supplements and as a cosmetic additive have been explored, and there is an increasing demand for ERG.(6) Mushrooms have traditionally been the source of ERG.(7) However, slow growth, low content, and time-consuming purification procedures lead to a high manufacturing cost. Therefore, alternative and sustainable sources of ERG are necessary.
One such reliable and practical method is a fermentative process using microorganisms, such as actinobacteria and cyanobacteria, that are known to produce ERG. However, their ERG productivities are very low (1.18 mg/g of dry weight after 4 weeks of cultivation of Mycobacterium avium and 0.8 mg/g of dry weight of Oscillatoria sp.),(2, 8) and thus, genetic and metabolic engineering are indispensable for industrial production. Until recently, however, there were no reports on ERG biosynthesis genes and enzymes. In 2010, five genes in Mycobacterium smegmatis, egtABCDE, were confirmed to be responsible for ERG biosynthesis (Figure 1).(9) In the biosynthetic pathway, EgtD catalyzes the formation of hercynine (HER) by transfer of three methyl groups derived from S-adenosylmethionine (SAM) to l-histidine (l-His). Then, EgtB catalyzes O2-dependent C–S bond formation between γ-glutamylcysteine (γGC) supplied by EgtA and HER to form hercynyl-γ-glutamylcysteine sulfoxide (γGC-HER). This is followed by removal of the l-glutamate (l-Glu) moiety by EgtC, an amidohydrolase, to produce hercynylcysteine sulfoxide (Cys-HER). Then, EgtE, a PLP-dependent C–S lyase, catalyzes the formation of ERG with concomitant formation of pyruvate and ammonia as side products.

Figure 1

Figure 1. ERG biosynthetic pathway.

In this study, we developed heterologous and high-level production of ERG in Escherichia coli using the egt genes from M. smegmatis. By high production of each of the Egt enzymes and elimination of bottlenecks in substrate supply, the production system yielded 24 mg/L (104 μM) secreted ERG.

Materials and Methods

ARTICLE SECTIONS
Jump To

General Procedures

Lysogeny broth (LB, Lennox) medium was purchased from Sigma-Aldrich Japan K.K. (Tokyo, Japan); l-methionine (l-Met) and l-His were obtained from Wako Pure Chemical Industry (Osaka, Japan); and HER was purchased from Shinsei Chemical Company, Ltd. (Osaka, Japan). Other chemicals were of analytical grade and purchased from Wako Pure Chemical Industry or Sigma-Aldrich Japan. Primers were obtained from FASMAC Co., Ltd. (Kanagawa, Japan). Enzymes and kits for DNA manipulation were purchased from Takara Bio, Inc. (Shiga, Japan) or New England BioLabs Japan, Inc. (Tokyo, Japan). Polymerase chain reaction (PCR) was carried out using a GeneAmp PCR System 9700 thermal cycler (Thermo Fisher Scientific, Inc., Waltham, MA, U.S.A.) with Tks Gflex DNA polymerase (Takara Bio). General genetic manipulations of E. coli were performed according to standard protocols. High-resolution electrospray ionization Fourier transform mass spectrometry (HR-ESI–FT–MS) analysis was performed using an Exactive system (Thermo Fisher Scientific, Inc.).

Bacterial Strains and Cultures

Microorganisms used in this study are summarized in Table 1. E. coli XL1-Blue (Nippon Gene Co., Ltd., Tokyo, Japan), BL21(DE3) (Merck KGaA, Darmstadt, Germany), and BW25113 (National Institute of Genetics, Shizuoka, Japan), which is a high producer of l-cysteine (l-Cys) used for a sulfur donor of ERG,(10) were used for plasmid construction, protein production, and ERG production, respectively. The media used were LB and M9Y minimal medium prepared by adding 1% (w/v) glucose, 5 mM MgSO4, 0.1 mM CaCl2, and 0.1% (w/v) yeast extract (Becton, Dickinson and Company, Franklin Lakes, NJ, U.S.A.) to M9 minimal salts (Becton, Dickinson and Company). Ampicillin (Ap), chloramphenicol (Cm), kanamycin (Km), streptomycin (Sm), and tetracycline (Tc) were added to the media at concentrations of 100, 33, 25, 20, and 5 mg/L, if necessary. Optical density (OD) at 600 nm was measured with a NanoDrop 2000C spectrophotometer (Thermo Fisher Scientific, Inc.).
Table 1. Bacterial Strains Used in This Study
straindescriptionsource
M. smegmatis JCM6386ERG producerJCMa
E. coli
XL1-BluehsdR17, recA1, endA1, gyrA96, thi-1, supE44, relA1, lac[F′, proAB, lacIqZΔM15, Tn10(TcR)]Nippon Gene
BL21(DE3)F, ompThsdSB(rB mB) galdcm (DE3)Merck
BW25113rrnB3 ΔlacZ4787hsdR514 Δ(araBAD)567 Δ(rhaBAD)568 rph-1NIGb
ET1BW25113 harboring pCF1s-MsDthis study
ET2BW25113 harboring pCF1s-MsD, pQE1a-mMsBthis study
ET3BW25113 harboring pCF1s-MsD, pQE1a-mMsB, pAC1c-hMsC/hMsEthis study
ET4BW25113 harboring pCF1s-MsD, pQE1a-mMsB/EcA, pAC1c-hMsC/hMsEthis study
a

Japan Collection of Microorganisms, Riken BioResource Center.

b

National Institute of Genetics.

Preparation of Egt Recombinant Enzymes

Detailed plasmid construction methods are described in Supplementary Methods 1 of the Supporting Information, and the plasmids are summarized in Table 2. Briefly, EgtB, EgtC, EgtD, and EgtE were amplified by PCR using M. smegmatis genomic DNA as the template and appropriate primers (Table S1 of the Supporting Information), in which restriction sites were introduced at the N and C termini. The PCR products were respectively cloned into the expression vectors. The plasmids obtained were introduced into E. coli BL21(DE3). A liquid culture of the transformant in LB supplied with appropriate antibiotics was induced by adding 0.5 mM isopropyl β-d-1-thiogalactopyranoside (IPTG) when the optical density at 600 nm reached about 0.6. The cultivation was continued for an additional 16 h at 20 °C. The production of each recombinant enzyme was analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS–PAGE) with Coomassie Brilliant Blue staining. The purification of each recombinant protein was carried out using nickel–nitrilotriacetic acid (Ni–NTA) agarose (QIAGEN K.K., Tokyo, Japan) or amylose resins (New England BioLabs) according to the protocols of the manufacturer. Protein concentrations were determined using a Bradford protein assay kit (Bio-Rad Laboratories, Inc., Hercules, CA, U.S.A.) with bovine serum albumin as the standard.
Table 2. Plasmids Used in This Study
plasmiddescriptionsource
pQE1a-Redprotein production plasmid, tac promoter, ColE1 ori, ApRlab stock
pCF1s-Redprotein production plasmid, tac promoter, CDF ori, SmRlab stock
pET-21aprotein production plasmid, T7 promoter, pBR322 ori, ApRMerck
pACYCDuet-1protein production plasmid, T7 promoter, p15A ori, CmRMerck
pQE1a-MsBpQE1a-Red derivative, production of EgtBthis study
pQE1a-mMsBpQE1a-MsB derivative, production of MBP-fused EgtBthis study
pQE1a-mMsB/EcApQE1a-mMsB derivative, co-production of MBP-fused EgtB and GshAthis study
pQE1a-MsCpQE1a-Red derivative, production of EgtCthis study
pQE1a-hMsCpQE1a-MsC derivative, production of His-tagged EgtCthis study
pQE1a-MsEpQE1a-Red derivative, production of EgtEthis study
pQE1a-hMsEpQE1a-Red derivative, production of His-tagged EgtEthis study
pAC1c-hMsC/hMsEpACYCDuet-1 derivative, co-production of His-tagged EgtC and EgtEthis study
pCF1s-MsDpCF1s-Red derivative, production of EgtDthis study

ERG Production

E. coli harboring plasmids carrying ERG biosynthetic genes (Figure 2) was cultured in 3 mL of M9Y media at 30 °C for 16 h. The cultures (1 mL) were inoculated into 50 mL of M9Y media supplemented with 0.5 g/L l-His, 0.5 g/L l-Met, and 20 mg/L FeSO4·7H2O in 200 mL Erlenmeyer flasks and incubated at 30 °C with shaking (200 rpm) for up to 72 h. Na2S2O3 was added to media at 20 mM, if needed. IPTG was added to a final concentration of 0.5 mM after 3 h of cultivation. Samples (1 mL) were collected at appropriate time points and analyzed by liquid chromatography–electrospray ionization–mass spectrometry (LC–ESI–MS).

Figure 2

Figure 2. Plasmids for ERG production.

LC–ESI–MS Analysis of Products

Mixtures of 0.05% (v/v) heptafluorobutyric acid (HFBA) solution (180 μL) and culture broth or enzymatic reaction solutions (20 μL) were analyzed. The LC–ESI–MS conditions were as follows: Waters ACQUITY UPLC system equipped with a photodiode array and a SQ Detector2 (Tokyo, Japan); XBridge BEH C18 XP column (150 mm length × 2.0 mm internal diameter, 2.5 μm, Waters); flow rate, 0.15 mL/min; temperature, 35 °C; mobile phase, water containing 0.05% HFBA and 7% methanol; injection volume, 2 μL; and detection, 210 nm for His and HER, 250 nm for Cys-HER and γGC-HER, and 258 nm for ERG.

Results and Discussion

ARTICLE SECTIONS
Jump To

The most reliable strategy for high production of ERG is overproduction of each of the enzymes for ERG biosynthesis and then optimization of any inefficient biosynthetic step(s) (identified by intermediate accumulation) by molecular genetics and metabolic engineering. If no intermediates accumulate, supply of the initial substrates, l-His, l-Glu, l-Cys, and l-Met, should be enhanced.
ERG biosynthetic genes are present in some microorganisms, such as actinobacteria, cyanobacteria, and α-proteobacteria.(11) Among these bacteria, we selected M. smegmatis as the gene source, because the ERG biosynthetic pathway was first identified in this strain and the biosynthesis genes constitute an operon.(9) Because egtB, egtC, and egtE are translationally coupled, we first tried expressing the egt genes as the operon with tac and T7 promoters. We constructed several plasmids using pQE1a-Red and pET-21a, but ERG productivities of transformants harboring the plasmids were low (less than 0.2 mg/L). Therefore, we overexpressed egt genes stepwise under the control of individual promoters by checking production of recombinant enzymes and their activities by production of intermediate compounds (HER, γGC-HER, and Cys-HER) and ERG by in vitro experiment (Figure 1). Because E. coli has an egtA orthologue, gshA, which is responsible for glutathione biosynthesis,(12) we expressed the other genes, egtB, egtC, egtD, and egtE. We also prepared the intermediate compounds, which are not commercially available, with the recombinant enzymes to obtain standards for quantitative analysis (Supplementary Methods 2 of the Supporting Information).

Overproduction of Recombinant Enzymes

For overproduction of Egt enzymes, we used pQE1a-Red and pCF1s-Red, both of which are home-constructed and compatible vectors with the tac promoter for protein production (Figure S1 of the Supporting Information). As Figure S2 of the Supporting Information shows, transformants harboring pCF1s-MsD carrying egtD overproduced EgtD in soluble form. To confirm whether the recombinant protein had the expected activity, we carried out in vitro experiments with cell-free extracts containing the recombinant enzyme.(9, 13) The cell-free extracts were incubated with l-His and excess SAM. After the reaction, the product was analyzed by LC–ESI–MS. A specific peak with the same retention time and mass spectrometry (MS) spectrum as the HER standard was clearly detected after 1 h of incubation, demonstrating that EgtD converted l-His into HER (Figure S3 of the Supporting Information).
We next overproduced recombinant EgtB using pQE1a-Red (Figure S1 of the Supporting Information) and changed the probable start codon TTG into ATG. However, recombinant EgtB formed inclusion bodies in multiple culture conditions. Therefore, a plasmid from which a recombinant enzyme is produced as a maltose binding protein (MBP)-fused enzyme was examined. We successfully produced a MBP-fused EgtB in a soluble form in transformants harboring pQE1a-mMsB. To confirm whether the recombinant enzyme had the expected activity, we carried out in vitro experiments with purified recombinant enzyme (Figure S4 of the Supporting Information).(9) The recombinant MBP-fused EgtB was incubated with HER and γGC for 2 h. As Figure S5 of the Supporting Information shows, HER completely disappeared and the formation of a new product with m/z 462.20 was detected. On the basis of HR-ESI–FT–MS analysis of the purified compound, the molecular formula of the product was determined to be C17H27O8N5S (m/z: [M + H]+ calculated for C17H28O8N5S+, 462.165 31; observed, 462.165 07), which corresponded to that of γGC-HER, suggesting the formation of γGC-HER. The thus formed intermediate compound γGC-HER was purified by high-performance liquid chromatography (HPLC) (Supplementary Methods 2 of the Supporting Information) and used as a standard for quantitative analysis.
Finally, overproduction of recombinant EgtC and EgtE was examined. We first used the same vector as for EgtB production, but no production of either enzyme was observed. We then examined a plasmid from which a recombinant enzyme is produced as a His-tagged enzyme. In this case, both EgtC and EgtE were successfully overproduced. To confirm whether the recombinant enzymes had the expected activity, we carried out in vitro experiments with the purified recombinant enzymes (Figure S4 of the Supporting Information).(9) Recombinant EgtC was incubated with enzymatically prepared γGC-HER. After 17 h of reaction, the product was analyzed by LC–ESI–MS. As shown in Figure 3, a new peak with m/z 333.23 was detected and Cys-HER formation was suggested. On the basis of HR-ESI–FT–MS analysis of the purified compound, the molecular formula of the product was determined to be C12H20O5N4S (m/z: [M + H]+ calculated for C12H21O5N4S+, 333.122 72; observed, 333.122 90), which corresponded to that of Cys-HER. The thus formed Cys-HER was purified (Supplementary Methods 2 of the Supporting Information) and used as a standard for quantitative analysis.

Figure 3

Figure 3. LC–ESI–MS analysis of EgtC reaction products. (a) Traces at 250 nm of reaction products. The reaction (40 μL) was carried out by adding (i) purified recombinant EgtC (3.9 μM) or (ii) boiled EgtC to the EgtB reaction solution at 25 °C for 17 h. (b) MS spectrum of the EgtC reaction product (ESI positive mode).

By adding recombinant EgtE together with EgtC into the EgtB reaction mixture, we confirmed the formation of ERG by LC–ESI–MS analysis (Figure 4), showing that all of the recombinant Egt enzymes possessed the expected activities.

Figure 4

Figure 4. LC–ESI–MS analysis of EgtE reaction products. (a) Traces at 250 nm of (i) ERG standard and (ii) reaction products. The reaction (40 μL) was carried out by adding purified recombinant EgtE (2.5 μM) and EgtC (3.9 μM) (ii) to the boiled supernatant of the EgtB reaction mixture containing 2 mM dithiothreitol at 25 °C for 17 h. (b) MS spectra of (i) ERG standard and (ii) EgtE reaction product (ESI positive mode).

Simultaneous Production of Egt Enzymes for ERG Production

To reconstruct the ERG-producing pathway in E. coli, we optimized the production conditions in a stepwise manner: HER, then γGC-HER, and finally ERG production (Figures 1 and 2).
The first step was HER production. E. coli BW25113 harboring pCF1s-MsD (named strain ET1) was cultured in M9Y medium, and 91 ± 2 mg/L HER (460 ± 10 μM) was produced in the culture broth after 48 h. We then carried out feeding experiments with l-His and l-Met, because amino acid biosynthesis in E. coli is strictly regulated by feedback inhibition and/or transcriptional repression. l-Met and l-His feeding increased the yield: 164 ± 3 mg/L HER (833 ± 15 μM) was produced after 48 h of cultivation (Figure 5). After this, l-His and l-Met feeding was employed in all in vivo production experiments.

Figure 5

Figure 5. Culture profiles of strain ET1. E. coli BW25113 harboring pCF1s-MsD (strain ET1) was cultured in M9Y medium supplemented with l-His and l-Met. After 3 h of cultivation, 0.5 mM IPTG was added to the medium. Data are presented as mean values with standard errors from three independent experiments.

We next carried out in vivo co-production of EgtD and EgtB for γGC-HER production. Transformants of E. coli BW25113 carrying both pCF1s-MsD and pQE1a-mMsB (strain ET2) were cultivated in the medium supplemented with l-His and l-Met. As Figure 6 shows, we confirmed 24 ± 1 mg/L γGC-HER (52 ± 2 μM) production after 24 h of cultivation, indicating that EgtB converted HER to γGC-HER using endogenous γGC in E. coli. However, accumulation of 3-fold higher amounts of HER (110 ± 5 mg/L) than Cys-HER (36 ± 2 mg/L) was detected, suggesting that γGC-HER production was rate-limiting.

Figure 6

Figure 6. Culture profiles of strain ET2. E. coli BW25113 harboring pCF1s-MsD and pQE1a-mMsB (strain ET2) was cultured in M9Y medium supplemented with l-His and l-Met. After 3 h of cultivation, 0.5 mM IPTG was added to the medium. Data are presented as mean values with standard errors from three independent experiments.

For simultaneous expression of all egt genes, egtC and egtE, both of which were expressed from the tac promoter of pQE1a, were recloned into plasmid pACYCDuet-1, which is compatible with pQE1a-Red and pCF1s-Red, to construct pAC1c-hMsC/hMsE (Figure 2 and Supplementary Methods 2 of the Supporting Information). The plasmid was successfully constructed, and production of both enzymes in soluble forms in E. coli was confirmed by SDS–PAGE (Figure S6 of the Supporting Information). The plasmid was introduced into strain ET2 to construct strain ET3, and recombinant enzyme production was examined. As Figure S7 of the Supporting Information shows, all of the enzymes were produced in soluble forms. We then examined ERG production. Strain ET3 produced 19 ± 2 mg/L (83 ± 8 μM) ERG together with 73 ± 15 mg/L (370 ± 76 μM) HER in the culture broth after 72 h of cultivation (Figure 7 and Table 3). These results suggested that the EgtB-catalyzed reaction is a bottleneck.

Figure 7

Figure 7. Culture profiles of strain ET3. E. coli BW25113 harboring pCF1s-MsD, pQE1a-mMsB, and pAC1c-hMsC/hMsE (strain ET3) was cultured in M9Y medium supplemented with l-His and l-Met. After 3 h of cultivation, 0.5 mM IPTG was added to the medium. Data are presented as mean values with standard errors from three independent experiments.

Table 3. Culture Profiles of ET3 and ET4 Strainsa
strainODHER (mg/L)γGC-HER (mg/L)Cys-HER (mg/L)ERG (mg/L)
ET3b10.1 ± 0.573 ± 15NDc10 ± 219 ± 2
ET4b8.7 ± 0.2121 ± 121 ± 19 ± 117 ± 1
ET3d11.1 ± 0.548 ± 17ND9 ± 024 ± 4
a

Data after 72 h of cultivation are presented as mean values with standard error from three independent experiments.

b

ET3 and ET4 were cultured in M9Y media supplemented with l-His and l-Met.

c

ND = not detected.

d

ET3 was cultured in M9Y media supplemented with l-His, l-Met, and thiosulfate.

ERG Production and Improvement of Rate-Limiting Steps

Considering that EgtB was overproduced in a soluble form in the producing strain ET3 and that it showed enough activity in in vitro experiments, we considered that insufficient supply of γGC, the substrate of EgtB, might cause the accumulation of HER. To test this hypothesis, overproduction of γGC synthetase was carried out. To produce γGC synthetase, the gshA gene from E. coli(12) was cloned and inserted into pQE1a-mMsB to construct pQE1a-mMsB/EcA. Although MBP-fused EgtB and GshA were produced in soluble forms in E. coli BW25113 harboring the three plasmids (strain ET4) (Figure S8 of the Supporting Information), ERG productivity was decreased in comparison to that of strain ET3 to 17 ± 1 mg/L (72 ± 2 μM) after 72 h of cultivation (Table 3). In comparison of SDS–PAGE data for strains ET3 and ET4 (Figures S7 and S8 of the Supporting Information), soluble MBP-fused EgtB was found to be decreased in strain ET4. This could be the reason for the reduced productivity.
We then employed another strategy to enhance the γGC supply. In ERG biosynthesis, γGC is used as a sulfur donor. In particular, l-Cys is a net sulfur donor, because the l-Glu moiety of γGC is released by EgtC. Therefore, reinforcement of l-Cys flux may be effective in enhancing γGC flux and ERG production. Because l-Cys addition into media was reported to be toxic to E. coli cells,(14) we employed another strategy. We have been studying a l-Cys biosynthetic pathway in E. coli and demonstrated that thiosulfate (S2O32–) was a better sulfur source than sulfate (SO42–) for high l-Cys production.(10) We therefore fed thiosulfate into the growth media. When strain ET3 was cultured in M9Y supplemented with l-Met, l-His, and thiosulfate, ERG productivity was increased to 24 ± 4 mg/L (104 ± 17 μM) (Table 3), indicating that reinforcement of l-Cys flux was very effective in enhancing the ERG production.
In conclusion, to establish a reliable and practical method for ERG supply, fermentative ERG production by microorganisms was investigated. We heterologously overexpressed genes egtBCDE of M. smegmatis in E. coli and succeeded in the production of ERG (19 mg/L). Reinforcement of the γGC supply by feeding of thiosulfate, a suitable sulfur donor for high l-Cys production, resulted in higher ERG production (24 mg/L). Considering that the reported ERG contents of mushrooms were from 0.15 to 7.27 mg/g of dry weight,(7) our system might become an alternative method for ERG supply. However, significant amounts of HER still accumulated, suggesting that more supply of γGC and l-Cys by metabolic engineering and use of another EgtB with higher activity are indispensable for high-level production of ERG.

Supporting Information

ARTICLE SECTIONS
Jump To

The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.jafc.7b04924.

  • Supplementary Methods 1 and 2, vectors pQE1a-Red and pCF1s-Red (Figure S1), SDS–PAGE analysis of EgtD production (Figure S2), LC–ESI–MS analysis of EgtD reaction products (Figure S3), SDS–PAGE analysis of purified recombinant EgtB, EgtC, and EgtE (Figure S4), LC–ESI–MS analysis of EgtB reaction products (Figure S5), SDS–PAGE analysis of recombinant EgtC and EgtE production (Figure S6), SDS–PAGE analysis of production of recombinant Egt enzymes in strain ET3 (Figure S7), SDS–PAGE analysis of production of recombinant Egt enzymes and GshA in strain ET4 (Figure S8), and primers used in this study (Table S1) (PDF)

Terms & Conditions

Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

Author Information

ARTICLE SECTIONS
Jump To

  • Corresponding Authors
    • Yasuharu Satoh - †Graduate School of Chemical Science and Engineering and ‡Graduate School of Engineering, Hokkaido University, Sapporo, Hokkaido 060-8628, JapanInnovation Medical Research Institute, University of Tsukuba, Tsukuba, Ibaraki 305-8550, JapanOrcidhttp://orcid.org/0000-0001-6671-7758 Email: [email protected]
    • Tohru Dairi - †Graduate School of Chemical Science and Engineering and ‡Graduate School of Engineering, Hokkaido University, Sapporo, Hokkaido 060-8628, JapanInnovation Medical Research Institute, University of Tsukuba, Tsukuba, Ibaraki 305-8550, JapanOrcidhttp://orcid.org/0000-0002-3406-7970 Email: [email protected]
  • Authors
    • Ryo Osawa - †Graduate School of Chemical Science and Engineering and ‡Graduate School of Engineering, Hokkaido University, Sapporo, Hokkaido 060-8628, JapanInnovation Medical Research Institute, University of Tsukuba, Tsukuba, Ibaraki 305-8550, Japan
    • Tomoyuki Kamide - †Graduate School of Chemical Science and Engineering and ‡Graduate School of Engineering, Hokkaido University, Sapporo, Hokkaido 060-8628, JapanInnovation Medical Research Institute, University of Tsukuba, Tsukuba, Ibaraki 305-8550, Japan
    • Yusuke Kawano - Innovation Medical Research Institute, University of Tsukuba, Tsukuba, Ibaraki 305-8550, Japan
    • Iwao Ohtsu - Innovation Medical Research Institute, University of Tsukuba, Tsukuba, Ibaraki 305-8550, Japan
  • Funding

    This work was supported by the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry (26027AB) from Ministry of Agriculture, Forestry and Fisheries (MAFF), Japan (to Iwao Ohtsu).

  • Notes

    The authors declare no competing financial interest.

Acknowledgment

ARTICLE SECTIONS
Jump To

The authors are grateful to Professor Tsutomu Sato (Graduate School of Science and Technology, Niigata University, Niigata, Japan) for providing M. smegmatis genomic DNA. The authors thank James Allen from Edanz Group (www.edanzediting.com) for editing a draft of this manuscript.

Nomenclature

ERG

ergothioneine

HER

hercynine

γGC

γ-glutamylcysteine

γGC-HER

hercynyl-γ-glutamylcysteine sulfoxide

Cys-HER

hercynylcysteine sulfoxide

SAM

S-adenosylmethionine

SAH

S-adenosylhomocysteine

l-His

l-histidine

l-Glu

l-glutamate

l-Cys

l-cysteine

l-Met

l-methionine

HR-ESI–FT–MS

high-resolution electrospray ionization Fourier transform mass spectrometry

MBP

maltose-binding protein

SDS–PAGE

sodium dodecyl sulfate polyacrylamide gel electrophoresis

References

ARTICLE SECTIONS
Jump To

This article references 14 other publications.

  1. 1
    Genghof, D. S. Biosynthesis of ergothioneine and hercynine by fungi and Actinomycetales J. Bacteriol. 1970, 103, 475 478
  2. 2
    Pfeiffer, C.; Bauer, T.; Surek, B.; Schömig, E.; Gründemann, D. Cyanobacteria produce high levels of ergothioneine Food Chem. 2011, 129, 1766 1769 DOI: 10.1016/j.foodchem.2011.06.047
  3. 3
    Pluskal, T.; Ueno, M.; Yanagida, M. Genetic and metabolomic dissection of the ergothioneine and selenoneine biosynthetic pathway in the fission yeast, S. pombe, and construction of an overproduction system. PLoS One 2014, 9, e97774 DOI: 10.1371/journal.pone.0097774
  4. 4
    Gründemann, D.; Harlfinger, S.; Golz, S.; Geerts, A.; Lazar, A.; Berkels, R.; Jung, N.; Rubbert, A.; Schömig, E. Discovery of the ergothioneine transporter Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 5256 5261 DOI: 10.1073/pnas.0408624102
  5. 5
    Cheah, I. K.; Halliwell, B. Ergothioneine; antioxidant potential, physiological function and role in disease Biochim. Biophys. Acta, Mol. Basis Dis. 2012, 1822, 784 793 DOI: 10.1016/j.bbadis.2011.09.017
  6. 6
    Aruoma, O. I.; Coles, L. S.; Landes, B.; Repine, J. E. Functional benefits of ergothioneine and fruit- and vegetable-derived nutraceuticals: Overview of the supplemental issue contents Prev. Med. 2012, 54, S4 S8 DOI: 10.1016/j.ypmed.2012.04.001
  7. 7
    Kalaras, M. D.; Richie, J. P.; Calcagnotto, A.; Beelman, R. B. Mushrooms: A rich source of the antioxidants ergothioneine and glutathione Food Chem. 2017, 233, 429 433 DOI: 10.1016/j.foodchem.2017.04.109
  8. 8
    Genghof, D. S.; Van Damme, O. Biosynthesis of ergothioneine and hercynine by mycobacteria J. Bacteriol. 1964, 87, 852 862
  9. 9
    Seebeck, F. P. In vitro reconstitution of Mycobacterial ergothioneine biosynthesis J. Am. Chem. Soc. 2010, 132, 6632 6633 DOI: 10.1021/ja101721e
  10. 10
    Kawano, Y.; Onishi, F.; Shiroyama, M.; Miura, M.; Tanaka, N.; Oshiro, S.; Nonaka, G.; Nakanishi, T.; Ohtsu, I. Improved fermentative l-cysteine overproduction by enhancing a newly identified thiosulfate assimilation pathway in Escherichia coli Appl. Microbiol. Biotechnol. 2017, 101, 6879 6889 DOI: 10.1007/s00253-017-8420-4
  11. 11
    Jones, G. W.; Doyle, S.; Fitzpatrick, D. A. The evolutionary history of the genes involved in the biosynthesis of the antioxidant ergothioneine Gene 2014, 549, 161 170 DOI: 10.1016/j.gene.2014.07.065
  12. 12
    Watanabe, K.; Yamano, Y.; Murata, K.; Kimura, A. The nucleotide sequence of the gene for γ-glutamylcysteine synthetase of Escherichia coli Nucleic Acids Res. 1986, 14, 4393 4400 DOI: 10.1093/nar/14.11.4393
  13. 13
    Vit, A.; Misson, L.; Blankenfeldt, W.; Seebeck, F. P. Ergothioneine biosynthetic methyltransferase EgtD reveals the structural basis of aromatic amino acid betaine biosynthesis ChemBioChem 2015, 16, 119 125 DOI: 10.1002/cbic.201402522
  14. 14
    Kari, C.; Nagy, Z.; Kovács, P.; Hernádi, F. Mechanism of the growth inhibitory effect of cysteine on Escherichia coli J. Gen. Microbiol. 1971, 68, 349 356 DOI: 10.1099/00221287-68-3-349

Cited By


This article is cited by 19 publications.

  1. Tomoyuki Kamide, Shun Takusagawa, Naoyuki Tanaka, Yasushi Ogasawara, Yusuke Kawano, Iwao Ohtsu, Yasuharu Satoh, Tohru Dairi. High Production of Ergothioneine in Escherichia coli using the Sulfoxide Synthase from Methylobacterium strains. Journal of Agricultural and Food Chemistry 2020, 68 (23) , 6390-6394. https://doi.org/10.1021/acs.jafc.0c01846
  2. Jason B. Hedges, Katherine S. Ryan. Biosynthetic Pathways to Nonproteinogenic α-Amino Acids. Chemical Reviews 2020, 120 (6) , 3161-3209. https://doi.org/10.1021/acs.chemrev.9b00408
  3. Yiwen Han, Xiuyang Tang, Yuting Zhang, Xuechao Hu, Lu-Jing Ren. The current status of biotechnological production and the application of a novel antioxidant ergothioneine. Critical Reviews in Biotechnology 2021, 149 , 1-26. https://doi.org/10.1080/07388551.2020.1869692
  4. Gloria A. Martinez-Medina, Mónica L. Chávez-González, Deepak Kumar Verma, L. Arely Prado-Barragán, Jose L. Martínez-Hernández, Adriana C. Flores-Gallegos, Mamta Thakur, Prem Prakash Srivastav, Cristóbal N. Aguilar. Bio-funcional components in mushrooms, a health opportunity: Ergothionine and huitlacohe as recent trends. Journal of Functional Foods 2021, 77 , 104326. https://doi.org/10.1016/j.jff.2020.104326
  5. Irwin K. Cheah, Barry Halliwell. Ergothioneine, recent developments. Redox Biology 2021, 37 , 101868. https://doi.org/10.1016/j.redox.2021.101868
  6. Anja R Stampfli, Wulf Blankenfeldt, Florian P Seebeck. Structural basis of ergothioneine biosynthesis. Current Opinion in Structural Biology 2020, 65 , 1-8. https://doi.org/10.1016/j.sbi.2020.04.002
  7. Irina Borodina, Louise C. Kenny, Cathal M. McCarthy, Kalaivani Paramasivan, Etheresia Pretorius, Timothy J. Roberts, Steven A. van der Hoek, Douglas B. Kell. The biology of ergothioneine, an antioxidant nutraceutical. Nutrition Research Reviews 2020, 33 (2) , 190-217. https://doi.org/10.1017/S0954422419000301
  8. Ying-Hao Yu, Hong-Yu Pan, Li-Qiong Guo, Jun-Fang Lin, Han-Lu Liao, Hao-Ying Li. Successful biosynthesis of natural antioxidant ergothioneine in Saccharomyces cerevisiae required only two genes from Grifola frondosa. Microbial Cell Factories 2020, 19 (1) https://doi.org/10.1186/s12934-020-01421-1
  9. Alice Maurer, Florian P. Seebeck. Reexamination of the Ergothioneine Biosynthetic Methyltransferase EgtD from Mycobacterium tuberculosis as a Protein Kinase Substrate. ChemBioChem 2020, 21 (20) , 2908-2911. https://doi.org/10.1002/cbic.202000232
  10. Wan-Ju Sun, Li Wang, Hao-Hao Liu, Yong-Jun Liu, Yu-Hong Ren, Feng-Qing Wang, Dong-Zhi Wei. Characterization and engineering control of the effects of reactive oxygen species on the conversion of sterols to steroid synthons in Mycobacterium neoaurum. Metabolic Engineering 2019, 56 , 97-110. https://doi.org/10.1016/j.ymben.2019.09.004
  11. Naoyuki Tanaka, Yusuke Kawano, Yasuharu Satoh, Tohru Dairi, Iwao Ohtsu. Gram-scale fermentative production of ergothioneine driven by overproduction of cysteine in Escherichia coli. Scientific Reports 2019, 9 (1) https://doi.org/10.1038/s41598-018-38382-w
  12. Steven A. van der Hoek, Behrooz Darbani, Karolina E. Zugaj, Bala Krishna Prabhala, Mathias Bernfried Biron, Milica Randelovic, Jacqueline B. Medina, Douglas B. Kell, Irina Borodina. Engineering the Yeast Saccharomyces cerevisiae for the Production of L-(+)-Ergothioneine. Frontiers in Bioengineering and Biotechnology 2019, 7 https://doi.org/10.3389/fbioe.2019.00262
  13. Phuong Nguyen-Tri, Van Nguyen, Tuan Nguyen. Biological Activity and Nanostructuration of Fe3O4-Ag/High Density Polyethylene Nanocomposites. Journal of Composites Science 2019, 3 (2) , 34. https://doi.org/10.3390/jcs3020034
  14. Mariko Kondoh, Takashi Hirasawa. l-Cysteine production by metabolically engineered Corynebacterium glutamicum. Applied Microbiology and Biotechnology 2019, 103 (6) , 2609-2619. https://doi.org/10.1007/s00253-019-09663-9
  15. Shun Takusagawa, Yasuharu Satoh, Iwao Ohtsu, Tohru Dairi. Ergothioneine production with Aspergillus oryzae. Bioscience, Biotechnology, and Biochemistry 2019, 83 (1) , 181-184. https://doi.org/10.1080/09168451.2018.1527210
  16. Saraswathy Nachimuthu, Ruckmani Kandasamy, Ramalingam Ponnusamy, Jack Deruiter, Muralikrishnan Dhanasekaran, Sivasudha Thilagar. L-Ergothioneine: A Potential Bioactive Compound from Edible Mushrooms. 2019,,, 391-407. https://doi.org/10.1007/978-981-13-6382-5_16
  17. , . Medicinal Mushrooms. 2019,,https://doi.org/10.1007/978-981-13-6382-5
  18. Yoshiko Fujitani, Kabir Md Alamgir, Akio Tani. Ergothioneine production using Methylobacterium species, yeast, and fungi. Journal of Bioscience and Bioengineering 2018, 126 (6) , 715-722. https://doi.org/10.1016/j.jbiosc.2018.05.021
  19. Yusuke Kawano, Kengo Suzuki, Iwao Ohtsu. Current understanding of sulfur assimilation metabolism to biosynthesize l-cysteine and recent progress of its fermentative overproduction in microorganisms. Applied Microbiology and Biotechnology 2018, 102 (19) , 8203-8211. https://doi.org/10.1007/s00253-018-9246-4
  • Abstract

    Figure 1

    Figure 1. ERG biosynthetic pathway.

    Figure 2

    Figure 2. Plasmids for ERG production.

    Figure 3

    Figure 3. LC–ESI–MS analysis of EgtC reaction products. (a) Traces at 250 nm of reaction products. The reaction (40 μL) was carried out by adding (i) purified recombinant EgtC (3.9 μM) or (ii) boiled EgtC to the EgtB reaction solution at 25 °C for 17 h. (b) MS spectrum of the EgtC reaction product (ESI positive mode).

    Figure 4

    Figure 4. LC–ESI–MS analysis of EgtE reaction products. (a) Traces at 250 nm of (i) ERG standard and (ii) reaction products. The reaction (40 μL) was carried out by adding purified recombinant EgtE (2.5 μM) and EgtC (3.9 μM) (ii) to the boiled supernatant of the EgtB reaction mixture containing 2 mM dithiothreitol at 25 °C for 17 h. (b) MS spectra of (i) ERG standard and (ii) EgtE reaction product (ESI positive mode).

    Figure 5

    Figure 5. Culture profiles of strain ET1. E. coli BW25113 harboring pCF1s-MsD (strain ET1) was cultured in M9Y medium supplemented with l-His and l-Met. After 3 h of cultivation, 0.5 mM IPTG was added to the medium. Data are presented as mean values with standard errors from three independent experiments.

    Figure 6

    Figure 6. Culture profiles of strain ET2. E. coli BW25113 harboring pCF1s-MsD and pQE1a-mMsB (strain ET2) was cultured in M9Y medium supplemented with l-His and l-Met. After 3 h of cultivation, 0.5 mM IPTG was added to the medium. Data are presented as mean values with standard errors from three independent experiments.

    Figure 7

    Figure 7. Culture profiles of strain ET3. E. coli BW25113 harboring pCF1s-MsD, pQE1a-mMsB, and pAC1c-hMsC/hMsE (strain ET3) was cultured in M9Y medium supplemented with l-His and l-Met. After 3 h of cultivation, 0.5 mM IPTG was added to the medium. Data are presented as mean values with standard errors from three independent experiments.

  • References

    ARTICLE SECTIONS
    Jump To

    This article references 14 other publications.

    1. 1
      Genghof, D. S. Biosynthesis of ergothioneine and hercynine by fungi and Actinomycetales J. Bacteriol. 1970, 103, 475 478
    2. 2
      Pfeiffer, C.; Bauer, T.; Surek, B.; Schömig, E.; Gründemann, D. Cyanobacteria produce high levels of ergothioneine Food Chem. 2011, 129, 1766 1769 DOI: 10.1016/j.foodchem.2011.06.047
    3. 3
      Pluskal, T.; Ueno, M.; Yanagida, M. Genetic and metabolomic dissection of the ergothioneine and selenoneine biosynthetic pathway in the fission yeast, S. pombe, and construction of an overproduction system. PLoS One 2014, 9, e97774 DOI: 10.1371/journal.pone.0097774
    4. 4
      Gründemann, D.; Harlfinger, S.; Golz, S.; Geerts, A.; Lazar, A.; Berkels, R.; Jung, N.; Rubbert, A.; Schömig, E. Discovery of the ergothioneine transporter Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 5256 5261 DOI: 10.1073/pnas.0408624102
    5. 5
      Cheah, I. K.; Halliwell, B. Ergothioneine; antioxidant potential, physiological function and role in disease Biochim. Biophys. Acta, Mol. Basis Dis. 2012, 1822, 784 793 DOI: 10.1016/j.bbadis.2011.09.017
    6. 6
      Aruoma, O. I.; Coles, L. S.; Landes, B.; Repine, J. E. Functional benefits of ergothioneine and fruit- and vegetable-derived nutraceuticals: Overview of the supplemental issue contents Prev. Med. 2012, 54, S4 S8 DOI: 10.1016/j.ypmed.2012.04.001
    7. 7
      Kalaras, M. D.; Richie, J. P.; Calcagnotto, A.; Beelman, R. B. Mushrooms: A rich source of the antioxidants ergothioneine and glutathione Food Chem. 2017, 233, 429 433 DOI: 10.1016/j.foodchem.2017.04.109
    8. 8
      Genghof, D. S.; Van Damme, O. Biosynthesis of ergothioneine and hercynine by mycobacteria J. Bacteriol. 1964, 87, 852 862
    9. 9
      Seebeck, F. P. In vitro reconstitution of Mycobacterial ergothioneine biosynthesis J. Am. Chem. Soc. 2010, 132, 6632 6633 DOI: 10.1021/ja101721e
    10. 10
      Kawano, Y.; Onishi, F.; Shiroyama, M.; Miura, M.; Tanaka, N.; Oshiro, S.; Nonaka, G.; Nakanishi, T.; Ohtsu, I. Improved fermentative l-cysteine overproduction by enhancing a newly identified thiosulfate assimilation pathway in Escherichia coli Appl. Microbiol. Biotechnol. 2017, 101, 6879 6889 DOI: 10.1007/s00253-017-8420-4
    11. 11
      Jones, G. W.; Doyle, S.; Fitzpatrick, D. A. The evolutionary history of the genes involved in the biosynthesis of the antioxidant ergothioneine Gene 2014, 549, 161 170 DOI: 10.1016/j.gene.2014.07.065
    12. 12
      Watanabe, K.; Yamano, Y.; Murata, K.; Kimura, A. The nucleotide sequence of the gene for γ-glutamylcysteine synthetase of Escherichia coli Nucleic Acids Res. 1986, 14, 4393 4400 DOI: 10.1093/nar/14.11.4393
    13. 13
      Vit, A.; Misson, L.; Blankenfeldt, W.; Seebeck, F. P. Ergothioneine biosynthetic methyltransferase EgtD reveals the structural basis of aromatic amino acid betaine biosynthesis ChemBioChem 2015, 16, 119 125 DOI: 10.1002/cbic.201402522
    14. 14
      Kari, C.; Nagy, Z.; Kovács, P.; Hernádi, F. Mechanism of the growth inhibitory effect of cysteine on Escherichia coli J. Gen. Microbiol. 1971, 68, 349 356 DOI: 10.1099/00221287-68-3-349
  • Supporting Information

    Supporting Information

    ARTICLE SECTIONS
    Jump To

    The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.jafc.7b04924.

    • Supplementary Methods 1 and 2, vectors pQE1a-Red and pCF1s-Red (Figure S1), SDS–PAGE analysis of EgtD production (Figure S2), LC–ESI–MS analysis of EgtD reaction products (Figure S3), SDS–PAGE analysis of purified recombinant EgtB, EgtC, and EgtE (Figure S4), LC–ESI–MS analysis of EgtB reaction products (Figure S5), SDS–PAGE analysis of recombinant EgtC and EgtE production (Figure S6), SDS–PAGE analysis of production of recombinant Egt enzymes in strain ET3 (Figure S7), SDS–PAGE analysis of production of recombinant Egt enzymes and GshA in strain ET4 (Figure S8), and primers used in this study (Table S1) (PDF)


    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

You’ve supercharged your research process with ACS and Mendeley!

STEP 1:
Click to create an ACS ID

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

OOPS

You have to login with your ACS ID befor you can login with your Mendeley account.

MENDELEY PAIRING EXPIRED
Your Mendeley pairing has expired. Please reconnect

This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. Read the ACS privacy policy.

CONTINUE